Basel, Switzerland

Rui Costa

This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rui Costa. Retrieved from https://idiyas.com/inventor/rui-costa-pc90m35f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rui Costa: Innovator in Pharmaceutical Patents

Introduction

Rui Costa is a notable inventor based in Basel, Switzerland. He has made significant contributions to the pharmaceutical industry, particularly in the development of innovative drug formulations. With a total of 3 patents to his name, Costa's work focuses on enhancing the efficacy and delivery of medications.

Latest Patents

One of Rui Costa's latest patents is for a ribociclib tablet. This patent discloses an oral tablet formulation of ribociclib, including its salt(s). One embodiment of this patent is directed to a tablet of ribociclib with a high drug load and an immediate release profile. Additionally, the patent describes a coated tablet of ribociclib, where the coating serves as an aqueous moisture barrier. Another embodiment highlights a coated tablet of ribociclib with an advanced moisture barrier coating, specifically using Opadry® amb II coating, which is PVA-based.

Career Highlights

Rui Costa is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative drug delivery systems and formulations that can significantly impact patient care.

Collaborations

Throughout his career, Rui Costa has collaborated with several talented professionals, including Bindhumadhavan Gururajan and Arnaud Grandeury. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Rui Costa's contributions to the field of pharmaceuticals through his patents and collaborations exemplify his commitment to innovation. His work continues to influence the development of effective drug formulations that enhance patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…